Researchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of the lesions that occur in chronic ...
Researchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of the lesions that occur in chronic ...
The kidney transplant rejection prophylaxis market is projected to experience steady growth, driven by the introduction of innovative therapi ...
As it is now, the transplant system treats kidneys from all Black donors as if they are at higher risk for failing, even ...
For the second consecutive year, Rudy Molinet, RN, MPH, FACHE has been named chair and Karen O’Byrne, CPA, MBA as vice chair of the Holy Cross Health Board of Directors. In addition, the board has ...
Cross-species transplantation will now be tested in human clinical trials in the US. (HealthDay News) — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials ...
Doctors will monitor each transplant patient for 24 weeks and require lifelong follow-ups to track health outcomes and potential risks such as pathogens that could cross from pigs to humans ...
Inflammation promotes a favorable local environment for stone formation, while lipid metabolism abnormalities may directly impair the kidneys’ ability to handle minerals (14, 15). Therefore, this ...
If successful, these studies could lead to the broader use of cross-species transplantation ... with three patients with kidney failure who are unlikely to receive a human organ within five ...
WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for kidney failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback